Abstract
Asymmetric cell division (ACD) is a mechanism used by stem cells to maintain the number of progeny. However, the epigenetic mechanisms regulating ACD remain elusive. Here we show that BRD4, a BET domain protein that binds to acetylated histone, is segregated in daughter cells together with H3K56Ac and regulates ACD. ITGB1 is regulated by BRD4 to regulate ACD. A long noncoding RNA (lncRNA), LIBR (LncRNA Inhibiting BRD4), decreases the percentage of stem cells going through ACD through interacting with the BRD4 mRNAs. LIBR inhibits the translation of BRD4 through recruiting a translation repressor, RCK, and inhibiting the binding of BRD4 mRNAs to polysomes. These results identify the epigenetic regulatory modules (BRD4, lncRNA LIBR) that regulate ACD. The regulation of ACD by BRD4 suggests the therapeutic limitation of using BRD4 inhibitors to treat cancer due to the ability of these inhibitors to promote symmetric cell division that may lead to tumor progression and treatment resistance.
Original language | English |
---|---|
Pages (from-to) | 154-165 |
Number of pages | 12 |
Journal | Nucleic Acids Research |
Volume | 52 |
Issue number | 1 |
DOIs | |
State | Published - 11 01 2024 |
Externally published | Yes |
Bibliographical note
© The Author(s) 2023. Published by Oxford University Press on behalf of Nucleic Acids Research.Keywords
- Asymmetric Cell Division
- Cell Cycle Proteins/genetics
- Epigenesis, Genetic
- Nuclear Proteins/metabolism
- RNA, Long Noncoding
- Transcription Factors/metabolism
- Cell Division
- Bromodomain Containing Proteins/metabolism